CMB
CAMBIUM FPO [CMB]
Healthcare · ASX Small Cap
$0.4900 +0.0%
Updated 7 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -9First seen: 2026-03-06
Score Breakdown
Technical60
Catalyst50
Sentiment50
Fundamental24
Momentum79
Risk Gate45
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Sustained volume spike (2.1x median) on DOWN trend
- Near support level (potential bounce)
- VPT accumulation divergence (bullish)
- Volatility contracting (breakout setup)
- 4C filed 2026-01-22
- Pre-revenue with limited cash
- Micro-cap ($5-20M) - high risk
- Capital raise activity (2 events)
- Dilution velocity warning (2 raises recently)
- Strong 12-1 momentum (+180%)
- Excellent risk-adjusted momentum (Sharpe 1.9)
- Volume-weighted momentum positive (3.26%/day)
- Pre-revenue company — Altman Z-Score not applicable
- Elevated dilution risk (2 recent capital raises)
- RBA hiking (-3pts)
Risk Signals
- MACD momentum weakening
- Negative 5-day momentum (-6.7%)
- Piotroski F-Score weak (2/9, low-confidence approx)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Overseas neutral (-3pts, S&P500 neutral, VIX 27)
Recent Catalysts
NONE Half Year Report and Accounts
NONE Proposed issue of securities - CMB
NONE Notice of General Meeting/Proxy Form
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-19 | Half Year Report and Accounts PRICE SENSITIVE |
| 2026-02-10 | Proposed issue of securities - CMB |
| 2026-02-10 | Notice of General Meeting/Proxy Form |
| 2026-01-22 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-19 | Proposed issue of securities - CMB |
Key Metrics
$11.3M
Market Cap
16K
Avg Volume
2.1x
Vol Ratio
$0.19 — $0.60
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | insufficient_data | Float: 0% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #114 of 122 · Sector avg: 43
View all Healthcare signals →